Giuseppe Remuzzi
Giuseppe Remuzzi is the director of the Mario Negri Institute for Pharmacological Research in Italy and a renowned nephrologist. He has gained recognition for his research in kidney diseases and the role of various dietary practices on health outcomes. Recently, he was in the news for his commentary on an American study that challenges the health benefits of intermittent fasting, particularly the '16:8' method, suggesting it may increase cardiovascular risks rather than promote longevity.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Italy | 1 | 8.00 | 0.09% | +0% | 60,461,826 | 56,087 | $2,000,000 | 1,855$ |
| Totals | 1 | 60,461,826 | 56,087 | $2,000,000 | 1,855$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Italy:
Giuseppe Remuzzi is the director of the Mario Negri Institute and spoke about the role of artificial intelligence in medicine.
8
Italy:
Giuseppe Remuzzi explained that there has never been a correlation between paracetamol use during pregnancy and autism.
5
Italy:
Giuseppe Remuzzi is the director of the Mario Negri Institute and comments on the safety of paracetamol during pregnancy.
8
Italy:
Professor Giuseppe Remuzzi expresses concern over the consequences of funding cuts on pandemic preparedness.
6
Italy:
Giuseppe Remuzzi is the director of the Mario Negri Institute for Pharmacological Research and a professor of Nephrology at the University of Milan.
4